Skip to main content
    I

    IQVIA Holdings Inc (IQV)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE

    $264.73
    -0.39 (-0.15%)

    Market Cap: $43.69B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    IQVIA Holdings Inc (IQV) Earnings: Report Dates and Results

    Updated Oct 27, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    IQVIA Holdings (IQV) is expected to report earnings on Feb 3, 2027. In the quarter ended Sep 30, 2026, IQVIA Holdings reported EPS of $2.95, above the $2.94 estimate. It beat the EPS estimate in each of the last 39 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    98%(39/40)
    Avg Surprise
    +1.67%
    Streak
    39 Q

    Upcoming Estimates

    Reports Feb 3, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$3.62
    Range$3.48 - $3.80
    19 analysts
    Revenue Consensus
    $4.58B
    Range$4.38B - $4.84B
    19 analysts
    Reports May 3, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$3.15
    Range$2.84 - $3.28
    11 analysts
    EPS Estimate DriftChange to current
    90d ago$3.18-1.0%
    60d ago$3.18-1.0%
    30d ago$3.18-1.1%
    7d ago$3.18-0.9%
    Current$3.15
    Revenue Consensus
    $4.44B
    Range$4.38B - $4.51B
    10 analysts

    Next Report

    IQV has an expected report date of Feb 3, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 5.8% above the $3.42 reported for the quarter ended Dec 31, 2025.

    IQV Earnings Call

    The latest IQV earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, IQV beat 39 and missed 1. Revenue for the quarter ended Sep 30, 2026 was $4.43B, up 8.0% from $4.10B a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$2.95$2.94N/A+0.34%Beat-1.7%172 up, 0 downOct 27, 2026$4.43B
    Jun 30, 2026$2.75$2.72N/A+1.10%Beat-2.1%180 up, 2 downJul 28, 2026$4.37B
    Mar 31, 2026$2.90$2.82$2.71 - $2.88+2.84%Beat+7.4%190 up, 3 downMay 5, 2026$4.15B
    Dec 31, 2025$3.42$3.40$3.34 - $3.43+0.59%Beat+9.6%191 up, 0 downFeb 5, 2026$4.36B
    Sep 30, 2025$3.00$2.98$2.92 - $3.05+0.67%Beat+5.6%192 up, 1 downOct 28, 2025$4.10B
    Jun 30, 2025$2.81$2.77$2.73 - $2.83+1.44%Beat+6.4%170 up, 2 downJul 22, 2025$4.02B
    Mar 31, 2025$2.70$2.63$2.60 - $2.68+2.66%Beat+6.3%191 up, 5 downMay 6, 2025$3.83B
    Dec 31, 2024$3.12$3.11$3.04 - $3.16+0.32%Beat+9.9%201 up, 0 downFeb 6, 2025$3.96B
    Sep 30, 2024$2.84$2.81$2.75 - $2.91+1.07%Beat+14.1%203 up, 1 downOct 31, 2024$3.90B
    Jun 30, 2024$2.64$2.56$2.43 - $2.62+3.13%Beat+8.6%201 up, 2 downJul 22, 2024$3.81B
    Mar 31, 2024$2.54$2.48$2.41 - $2.53+2.42%Beat+3.7%191 up, 0 downMay 2, 2024$3.74B
    Dec 31, 2023$2.84$2.82$2.80 - $2.85+0.71%Beat+2.2%181 up, 0 downFeb 14, 2024$3.87B
    Sep 30, 2023$2.49$2.45$2.35 - $2.49+1.63%Beat+0.4%184 up, 1 downNov 1, 2023$3.74B
    Jun 30, 2023$2.43$2.37$2.30 - $2.44+2.53%Beat-0.4%201 up, 1 downAug 1, 2023$3.73B
    Mar 31, 2023$2.45$2.41N/A+1.66%Beat-0.8%200 up, 0 downApr 27, 2023$3.65B
    Dec 31, 2022$2.78$2.76$2.71 - $2.80+0.72%Beat+9.0%191 up, 1 downFeb 10, 2023$3.74B
    Sep 30, 2022$2.48$2.38$2.30 - $2.42+4.20%Beat+14.3%161 up, 0 downOct 26, 2022$3.56B
    Jun 30, 2022$2.44$2.38N/A+2.52%Beat+14.6%N/A1 up, 0 downJul 21, 2022$3.54B
    Mar 31, 2022$2.47$2.42$2.36 - $2.46+2.07%Beat+13.3%171 up, 1 downApr 27, 2022$3.57B
    Dec 31, 2021$2.55$2.43$2.40 - $2.48+4.94%Beat+20.9%18N/AFeb 15, 2022$3.64B
    Sep 30, 2021$2.17$2.12$2.09 - $2.27+2.36%Beat+33.1%190 up, 0 downOct 21, 2021$3.39B
    Jun 30, 2021$2.13$2.08$2.02 - $2.17+2.40%Beat+80.5%18N/AJul 27, 2021$3.44B
    Mar 31, 2021$2.18$1.86$1.82 - $1.90+17.20%Beat+45.3%18N/AApr 22, 2021$3.41B
    Dec 31, 2020$2.11$2.00$1.97 - $2.04+5.50%Beat+21.3%20N/AFeb 10, 2021$3.30B
    Sep 30, 2020$1.63$1.54$1.23 - $1.58+5.84%Beat+1.9%20N/AOct 20, 2020$2.79B
    Jun 30, 2020$1.18$1.06$1.03 - $1.14+11.32%Beat-22.9%21N/AJul 22, 2020$2.52B
    Mar 31, 2020$1.50$1.48$1.46 - $1.52+1.35%Beat-2.0%17N/AApr 28, 2020$2.75B
    Dec 31, 2019$1.74$1.72$1.68 - $1.76+1.16%Beat+16.0%18N/AFeb 12, 2020$2.90B
    Sep 30, 2019$1.60$1.57$1.55 - $1.60+1.91%Beat+12.7%17N/AOct 30, 2019$2.77B
    Jun 30, 2019$1.53$1.49$1.47 - $1.52+2.68%Beat+18.6%18N/AJul 24, 2019$2.74B
    Mar 31, 2019$1.53$1.51$1.46 - $1.54+1.32%Beat+14.2%18N/AMay 1, 2019$2.68B
    Dec 31, 2018$1.50$1.47$1.45 - $1.51+2.04%Beat+7.1%20N/AFeb 14, 2019$2.69B
    Sep 30, 2018$1.42$1.39$1.37 - $1.44+2.16%Beat+19.3%20N/AOct 22, 2018$2.59B
    Jun 30, 2018$1.29$1.23$1.21 - $1.26+4.88%Beat+18.3%18N/AJul 24, 2018$2.57B
    Mar 31, 2018$1.34$1.27$1.24 - $1.32+5.51%Beat+32.7%16N/AMay 2, 2018$2.56B
    Dec 31, 2017$1.40$1.34$1.31 - $1.38+4.48%Beat+204.3%19N/AFeb 14, 2018$2.52B
    Sep 30, 2017$1.19$1.14N/A+4.39%Beat+19.0%N/AN/AOct 26, 2017$2.47B
    Jun 30, 2017$1.09$1.05N/A+3.81%Beat+17.2%N/AN/AAug 3, 2017$2.35B
    Mar 31, 2017$1.01$0.96N/A+5.21%Beat+13.5%N/AN/AMay 3, 2017$2.36B
    Dec 31, 2016$0.46$1.05N/A-56.19%Miss-48.9%N/AN/AFeb 14, 2017$2.27B
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $11.93, up 7.1% from the year before. It was $3.28 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$11.93+7.1%
    Dec 31, 2024$11.14+9.1%
    Dec 31, 2023$10.21N/A
    Dec 31, 2022$10.17+12.6%
    Dec 31, 2021$9.03+40.7%
    Dec 31, 2020$6.42N/A
    Dec 31, 2019$6.40+15.3%
    Dec 31, 2018$5.55+18.3%
    Dec 31, 2017$4.69+43.0%
    Dec 31, 2016$3.28N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 6,700 words across 11 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20266,73911
    2026Q2Jun 30, 20265,99313
    2026Q1Mar 31, 20265,43010
    2025Q4Dec 31, 20255,40510
    2025Q3Sep 30, 20255,71012
    2025Q2Jun 30, 20256,09814
    2025Q1Mar 31, 20256,06110
    2024Q4Dec 31, 20245,17211

    2026Q3 Earnings Call

    Opening remarks

    Kerri Joseph Senior Vice President, Investor Relations Thank you all. Good morning, everyone. Thank you for joining our third quarter 2026 earnings call. With me today are Ari Bousbib, Chairman and Chief Executive Officer; Michael J. Fedock, Executive Vice President and Chief Financial Officer; Eric Sherbet, Executive Vice President and General Counsel; Clarissa Willett, Senior Vice President of Financial Planning and Analysis; and Katie Ward, Vice President, Investor Relations. Today, we will be referencing a presentation that will be visible during this call to those of you on our webcast. This presentation will also be available following this call in the Events and Presentations section of our IQVIA Investor Relations website at ir.iqvia.com. Before we begin, I would like to caution listeners that certain information discussed by management during this conference call will include forward-looking statements. Actual results could differ materially from those stated or implied by forward-looking statements due to risks and uncertainties associated with the company's business, which are discussed in the company's filings with the Securities and Exchange Commission, including our annual report on Form 10-K and subsequent SEC filings. In addition, we will discuss certain non-GAAP financial measures on this call, which should be considered a supplement to, and not a substitute for, financial measures prepared in accordance with GAAP. A reconciliation of these non-GAAP measures to comparable GAAP measures is included in the press release and conference call presentation. As previously disclosed, we implemented a new reporting structure that is effective January 1, 2026. In conjunction with this change, prior-period amounts have been recast to conform to this reporting structure. I would now like to turn the call over to our Chairman and CEO, Ari Bousbib.

    Ari Bousbib Chairman and Chief Executive Officer Thank you, Kerri, and good morning, everyone. Thank you for joining us today to discuss our third quarter results. The team delivered great numbers. The market environment has continued to improve, but our performance improved even more. Our organic growth rates year over year accelerated meaningfully: two times for commercial and nearly three times for clinical. Our margins expanded, and free cash flow was very strong. Our win rates were higher in the quarter, which led to our strongest clinical bookings in four years. Our differentiated AI offerings are increasingly contributing to that momentum, with continued adoption of our agentic solutions. In fact, IQVIA has now deployed 415 agents to date. Earlier this month, we brought together more than 400 attendees at Tech IQ to share our latest clinical and commercial AI capabilities. This event is our annual customer event focused on technology, which this year took place in Boston and included our technology partners NVIDIA, Microsoft, AWS, Snowflake, and Veeva.

    Frequently Asked Questions About IQV

    When is IQVIA Holdings's next earnings date?

    IQVIA Holdings's next earnings report is expected for Feb 3, 2027.

    Did IQV beat earnings estimates last quarter?

    Yes. IQVIA Holdings reported EPS of $2.95 for the quarter ended Sep 30, 2026, above the $2.94 estimate, a 0.34% surprise.

    What EPS do analysts expect from IQV next quarter?

    The consensus EPS estimate for IQVIA Holdings for the quarter ending Dec 31, 2026 is $3.62 from 19 analysts, with estimates from $3.48 to $3.80.

    How often does IQV beat earnings estimates?

    IQVIA Holdings beat the EPS estimate in each of the last 39 quarters, with an average surprise of +3.16%.